Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 2
1991 2
1992 1
1993 1
1994 2
1996 1
1998 1
1999 3
2000 4
2001 2
2002 4
2003 2
2004 2
2005 3
2006 9
2007 12
2008 9
2009 6
2010 11
2011 10
2012 12
2013 16
2014 22
2015 16
2016 23
2017 17
2018 14
2019 24
2020 19
2021 25
2022 17
2023 20
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.
Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Benedict RHB, et al. Lancet Neurol. 2020 Oct;19(10):860-871. doi: 10.1016/S1474-4422(20)30277-5. Epub 2020 Sep 16. Lancet Neurol. 2020. PMID: 32949546 Free PMC article. Review.
Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a sometimes neglected, yet common, sign and symptom with a profound effect on instrumental activities of daily living. The prevalence of cognitive impa …
Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a sometimes neglected …
Cognitive impairment in multiple sclerosis: diagnosis and monitoring.
Meca-Lallana V, Gascón-Giménez F, Ginestal-López RC, Higueras Y, Téllez-Lara N, Carreres-Polo J, Eichau-Madueño S, Romero-Imbroda J, Vidal-Jordana Á, Pérez-Miralles F. Meca-Lallana V, et al. Neurol Sci. 2021 Dec;42(12):5183-5193. doi: 10.1007/s10072-021-05165-7. Epub 2021 Apr 1. Neurol Sci. 2021. PMID: 33796947 Free PMC article. Review.
INTRODUCTION: Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), producing a negative impact on their quality of life, personal life, and work. ...METHODS: A multidisciplinary panel of professionals from the fi …
INTRODUCTION: Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produ …
Recommendations for cognitive screening and management in multiple sclerosis care.
Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, Gingold J, Goverover Y, Halper J, Harris C, Kostich L, Krupp L, Lathi E, LaRocca N, Thrower B, DeLuca J. Kalb R, et al. Mult Scler. 2018 Nov;24(13):1665-1680. doi: 10.1177/1352458518803785. Epub 2018 Oct 10. Mult Scler. 2018. PMID: 30303036 Free PMC article. Review.
PURPOSE: To promote understanding of cognitive impairment in multiple sclerosis (MS), recommend optimal screening, monitoring, and treatment strategies, and address barriers to optimal management. ...RECOMMENDATIONS: Based on current evidence, the Soci …
PURPOSE: To promote understanding of cognitive impairment in multiple sclerosis (MS), recommend optimal screenin …
Cognitive Impairment in Multiple Sclerosis.
Maiese K. Maiese K. Bioengineering (Basel). 2023 Jul 23;10(7):871. doi: 10.3390/bioengineering10070871. Bioengineering (Basel). 2023. PMID: 37508898 Free PMC article. Review.
Almost three million individuals suffer from multiple sclerosis (MS) throughout the world, a demyelinating disease in the nervous system with increased prevalence over the last five decades, and is now being recognized as one significant etiology of cognitive …
Almost three million individuals suffer from multiple sclerosis (MS) throughout the world, a demyelinating disease in the nerv …
Cognitive Impairment in Multiple Sclerosis.
Trenova AG, Slavov GS, Manova MG, Aksentieva JB, Miteva LD, Stanilova SA. Trenova AG, et al. Folia Med (Plovdiv). 2016 Sep 1;58(3):157-163. doi: 10.1515/folmed-2016-0029. Folia Med (Plovdiv). 2016. PMID: 27760012 Review.
Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. ...The relationship between pathological brain findings and cognitive impairme …
Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection …
Importance of Identifying Cognitive Impairment in Multiple Sclerosis.
Morrow SA, Baldwin C, Alkabie S. Morrow SA, et al. Can J Neurol Sci. 2023 Nov;50(6):813-819. doi: 10.1017/cjn.2022.334. Epub 2022 Dec 12. Can J Neurol Sci. 2023. PMID: 36503630 Review.
This article aims to highlight the impact of cognitive impairment on outcomes and quality of life for people with multiple sclerosis (MS) and to review current evidence for the efficacy of disease-modifying therapies (DMTs) and other interventions. ... …
This article aims to highlight the impact of cognitive impairment on outcomes and quality of life for people with multiple …
Cognitive impairment in multiple sclerosis: Utility of electroencephalography.
Jamoussi H, Ali NB, Missaoui Y, Cherif A, Oudia N, Anane N, Ftouhi L, Mahmoud MB, Fray S, Fredj M. Jamoussi H, et al. Mult Scler Relat Disord. 2023 Feb;70:104502. doi: 10.1016/j.msard.2023.104502. Epub 2023 Jan 4. Mult Scler Relat Disord. 2023. PMID: 36657327
OBJECTIVE: to evaluate associations between neurocognitive impairment and electroencephalography (EEG) data in Multiple Sclerosis (MS). METHODS: patients aged between 18 and 65 years, diagnosed with MS accordingly to the McDonald 2017 criteria and who were in …
OBJECTIVE: to evaluate associations between neurocognitive impairment and electroencephalography (EEG) data in Multiple Scl …
Is cognitive impairment in multiple sclerosis reversible?
Giovannoni G, Hawkes C, Levy M, Waubant E. Giovannoni G, et al. Mult Scler Relat Disord. 2018 Jul;23:A1. doi: 10.1016/j.msard.2018.07.007. Mult Scler Relat Disord. 2018. PMID: 30049507 No abstract available.
Cognitive impairment in multiple sclerosis: "classic" knowledge and recent acquisitions.
Piacentini C, Argento O, Nocentini U. Piacentini C, et al. Arq Neuropsiquiatr. 2023 Jun;81(6):585-596. doi: 10.1055/s-0043-1763485. Epub 2023 Jun 28. Arq Neuropsiquiatr. 2023. PMID: 37379870 Free PMC article.
Multiple sclerosis causes motor, sensory, cerebellar, and autonomic dysfunctions, as well as cognitive and psychoemotional impairment. ...There is currently limited evidence regarding the efficacy, on cognitive impairment, of disease-modi …
Multiple sclerosis causes motor, sensory, cerebellar, and autonomic dysfunctions, as well as cognitive and psychoemotio …
Cognitive impairment in multiple sclerosis.
Jongen PJ, Ter Horst AT, Brands AM. Jongen PJ, et al. Minerva Med. 2012 Apr;103(2):73-96. Minerva Med. 2012. PMID: 22513513 Review.
Cognitive impairment occurs in 40-65% of multiple sclerosis (MS) patients, typically involving complex attention, information processing speed, (episodic) memory and executive functions. ...Screening tools are the Brief Repeatable Neuropsychological Ba …
Cognitive impairment occurs in 40-65% of multiple sclerosis (MS) patients, typically involving complex attention …
285 results